Efficient generation of autologous peripheral blood-derived cytotoxic T lymphocytes against poorly immunogenic human tumors using recombinant CD80 adenovirus together with interleukin 12 and interleukin 2

Clinical Cancer Research

Volumn 4, Issue 3, 1998, Pages 713-720

  Mogi, Seiki ^a,b   Ebata, Tomohiko ^c   Setoguchi, Yasuhiro ^d   Fujime, Makoto ^d   Heike, Yuji ^d   Kohsaka, Takao ^a   Yagita, Hideo ^e   Okumura, Ko ^f   Azuma, Miyuki ^a,d  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c KANEBO LTD   (Japan)

^d JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD3 ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 2; MONOCLONAL ANTIBODY CD3; VIRUS VECTOR;

ADENOVIRUS; ADOPTIVE IMMUNOTHERAPY; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; LUNG CARCINOMA; MELANOMA; MOUTH CARCINOMA; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; ADENOVIRIDAE; ANTIGENS, CD80; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; CYTOTOXICITY, IMMUNOLOGIC; GENETIC VECTORS; HUMANS; INTERLEUKIN-12; INTERLEUKIN-2; LUNG NEOPLASMS; MELANOMA; MOUTH NEOPLASMS; NEOPLASMS; RECOMBINANT PROTEINS; RECOMBINATION, GENETIC; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0031901048     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Azuma, M., Cayabyab, M., Buck, D., Phillips, J. H., and Lanier, L. L. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes. J. Exp. Med., 775: 353-360, 1992.
2. Azuma, M., Ito, D., Yagita, H., Okumura, K., Phillips, J. H., Lanier, L. L., and Somoza, C. B70 antigen is a second ligand for CTLA-4 and CD28. Nature (Lond.), 366: 76-79, 1993.
3. Lanier, L. L., O'Fallon, S., Somoza, C., Phillips, J. H., Linsley, P. S., Okumura, K., and Azuma, M. CD80(B7) and CD86(B70) provide similar costimulatory signals for T cell proliferation, cytokine production and generation of cytotoxic T lymphocytes. J. Immunol., 154: 97-105, 1995.
4. Chen, L., McGowan, P., Ashe, S., Johnson, J., LI, Y., Hellström, I., and Hellström, K. E. Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity. J. Exp. Med., 179: 523-532, 1994.
5. Ramarathinam, L., Castle, M., Wu, Y., and Liu, Y. T cell costimulation by B7/BB1 induces CD8 T cell-dependent tumor rejection: an important role of B7/BB1 in the induction, recruitment, and effector function of antitumor T cells. J. Exp. Med., 179: 1205-1214, 1994.
6. + T cells by B7-transfected melanoma cells. Science (Washington DC), 259: 368-370, 1993.
7. Dohring, C., Angman, L., Spagnoli, G., and Lanzavecchia, A. T-helper and accessory-cell-independent cytotoxic responses to human tumor cells transfected with a B7 retroviral vector. Int. J. Cancer, 57: 754-759, 1994.
8. Sulé-Suso, J., Arienti, F., Melani, C., Colombo, M. P., and Parmiani, G. A B7-1-transfected human melanoma line stimulates proliferation and cytotoxicity of autologous and allogeneic lymphocytes. Eur. J. Immunol., 25: 2737-2742, 1995.
9. Kaufmann, A. M., Gissmann, L., Street, D., Schreckenberger, C., Hunter, M., and Qiao, L. Expression of CD80 enhances immunogenicity of cervical carcinoma cells in vitro. Cell. Immunol., 169: 246-251, 1996.
10. Boon, T., and van der Bruggen, P. Human tumor antigens recognized by T lymphocytes. J. Exp. Med., 183: 725-729, 1996.
11. Houghton, A. N. Cancer antigens: immune recognition of self and altered self. J. Exp. Med., 180: 1-4, 1994.
12. Pardoll, D. M. Cancer vaccines. Immunol. Today, 14: 310-316, 1993.
13. Bertagnolli, M. M., Lin, B. Y., Young, D., and Herrmann, S. H. IL-12 augments antigen-dependent proliferation of activated T lymphocytes. J. Immunol., 149: 3778-3783, 1992.
14. Chouaib, S., Chehimi, J., Bani, L., Genetet, N., Tursz, T., Gay, F., Trinchieri, G., and Mami-Chouaib, F. Interleukin 12 induces the differentiation of major histocompatibility complex class I-primed cytotoxic T-lymphocyte precursors into allospecific cytotoxic effectors. Proc. Natl. Acad. Sci. USA, 91: 12659-12663, 1994.
15. Gately, M. K., Wolitzky, A. G., Quinn, P. M., and Chizzonite, R. Regulation of human cytolytic lymphocyte responses by interleukin-12. Cell. Immunol., 143: 127-142, 1992.
16. + T lymphocytes. J. Immunol., 151: 2444-2452, 1993.
17. Caruso, M., Pham-Nguyen, K., Kwong, Y-L., Xu, B., Kosai, K-I., Finegold, M., Woo, S. L. C., and Chen, S-H. Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma. Proc. Natl. Acad. Sci. USA, 93: 11302-11306, 1996.
18. Zitvogel, L., Tahara, H., Robbins, P. D., Storkus, W. J., Clarke, M. R., Nalesnik, M. A., and Lotze, M. T., Cancer Immunotherapy of established tumors with IL-12: effective delivery by genetically engineered fibroblasts. J. Immunol., 155: 1393-1403, 1995.
19. Murphy, E. E., Terres, G., Macatonia, S. E., Hsieh, C-S., Mattson, J., Lanier, L., Wysocka, M., Trinchieri, G. K. M., and O'Garra, A. B7 and interleukin-12 cooperate for proliferation and IFN-γ production by mouse Th1 clones that are unresponsive to B7 costimulation. J. Exp. Med., 180: 223-231, 1994.
20. Zitvogel, L., Robbins, P. D., Storkus, W. J., Clarke, M. R., Maeurer, M. J., Cambell, R. L., Davis, C. G., Tahara, H., Schreiber, R. D., and Lotze, M. T. Interleukin-12 and B7.1 co-stimulation cooperate in the induction of effective antitumor immunity and therapy of established tumors. Eur. J. Immunol., 26: 1335-1341, 1996.
21. Coughlin, C. M., Wysocka, M., Kurzawa, H. L., Lee, W. M., Trinchieri, G., and Eck, S. L. B7-1 and interleukin 12 synergistically induce effective antitumor immunity. Cancer Res., 55: 4980-4987, 1995.
22. Browning, M. J., Krausa, P., Rowan, A., Bicknell, D. C., Bodmer, J. G., and Bodmer, W. F., Tissue typing the HLA-A locus from genomic DNA by sequence-specific PCR: comparison of HLA genotype and surface expression on colorectal tumor cell lines. Proc. Natl. Acad. Sci. USA, 90: 2842-2845, 1993.
23. Lanier, L. L., and Recktenwald, D. J. Multicolor immunofluorescence and flow cytometry. Methods, 2: 192-199, 1991.
24. Whiteside, T. L., Miescher, S., MacDonald, H. R., and von Fliedner, V. Separation of tumor-infiltrating lymphocytes from tumor cells in human solid tumors: a comparison between velocity sedimentation and discontinuous density gradients. J. Immunol. Methods, 90: 221-233, 1986.
25. Azuma, M., Cayabyab, M., Buck, D., Phillips, J. H., and Lanier, L. L. Involvement of CD28 in major histocompatibility complex-unrestricted cytotoxicity mediated by a human NK leukemia cell line. J. Immunol., 149: 1115-1123, 1992.
26. Setoguchi, Y., Jaffe, H. A., Danel, C., and Crystal, R. G. Ex vivo and in vivo gene transfer to the skin using replication-deficient recombinant adenovirus vectors. J. Invest. Dermatol., 102: 415-421, 1994.
27. Kanegae, Y., Makimura, M., and Saito, I. A simple and efficient method for purification of infectious recombinant adenovirus. Jpn. J. Med. Sci. Biol., 47: 157-166, 1994.
28. Lanzavecchia, A. Identifying strategies for immune intervention. Science (Washington DC), 260: 937-944, 1993.
29. Cayeux, S., Beck, C., Aicher, A., Dorken, B., and Blankenstein, T. Tumor cells cotransfected with interleukin-7 and B7.1 genes induce CD25 and CD28 on tumor-infiltrating T lymphocytes and are strong vaccines. Eur. J. Immunol., 25: 2325-2331, 1995.
30. Gajewski, T. F., Renauld, J-C., van Pel, A., and Boon, T. Costimulation with B7-1, IL-6, and IL-12 is sufficient for primary generation of murine antitumor cytolytic T lymphocytes in vitro. J. Immunol., 154: 5637-5648, 1995.
31. Li, Y., Hellström, K. E., Newby, S. A., and Chen, L. Costimulation by CD48 and B7-1 induces immunity against poorly immunogenic tumors. J. Exp. Med., 183: 639-644, 1996.
32. + melanoma-infiltrating lymphocytes. Eur. J. Immunol., 25: 2732-2736, 1995.
33. Stevens, E. J., Jacknin, L., Robbins, P. F., Kawakami, Y., Gamil, M. E., Rosenberg, S. A., and Yannelli, J. R. Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines: fine specificity and MART-1 melanoma antigen recognition. J. Immunol., 154: 762-771, 1995.
34. + T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene. Proc. Natl. Acad. Sci. USA, 91: 9461-9465, 1994.
35. Crowly, N. J., Darrow, T. L., Quinn-Allen, M. A., and Siegler, H. MHC-restricted recognition of autologous melanoma by tumor specific cytotoxic T cells: evidence for restriction by dominant HLA-A antigen. J. Immunol., 146: 1692-1699, 1991.
36. Zeh, H. J., III, Hurd, S., Storkus, W. J., and Lotze, M. T. Interleukin-12 promotes the proliferation and cytolytic maturation of immune effectors: implication for the immunotherapy of cancer. J. Immunother., 14: 155-161, 1993.
37. Rosenberg, S. A., Spiess, P., and Lafreniere, R. A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science (Washington DC), 233: 1318-1321, 1986.